Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice

Chuck Locuson, Sebastien Ronseaux, Michael McVay

Open source

DOI
10.1002/bdd.70037
Published
2026-09-17
Container
Biopharmaceutics & Drug Disposition
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/bdd.70037,
  title = {Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice},
  author = {Chuck Locuson and Sebastien Ronseaux and Michael McVay},
  year = {2026},
  journal = {Biopharmaceutics \& Drug Disposition},
  doi = {10.1002/bdd.70037},
  url = {https://doi.org/10.1002/bdd.70037}
}

RIS

TY  - JOUR
TI  - Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice
AU  - Chuck Locuson
AU  - Sebastien Ronseaux
AU  - Michael McVay
PY  - 2026
JO  - Biopharmaceutics & Drug Disposition
DO  - 10.1002/bdd.70037
UR  - https://doi.org/10.1002/bdd.70037
ER  - 

APA

Locuson, C., Ronseaux, S., & McVay, M. (2026). Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70037

Source records